Technical Analysis for SOLY - Soliton, Inc.

Grade Last Price % Change Price Change
grade B 14.42 9.24% 1.22
SOLY closed up 9.24 percent on Monday, October 21, 2019, on 1.75 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Oct 25

*** please verify all earnings dates ***
8 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical SOLY trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Narrow Range Bar Range Contraction 9.24%
NR7 Range Contraction 9.24%
Inside Day Range Contraction 9.24%

Older signals for SOLY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
SOLY Chart by TradingView
Basic chart:
Profile
Soliton, Inc. is a pre-revenue stage medical device company with a novel and proprietary platform technology licensed from MD Anderson. The Company’s first commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos. The Company is based in Houston, Texas, and is actively engaged in bringing this device to the market. The Company expects to file for premarket clearance with the U.S. Food and Drug Administration ("FDA") for its first device in the first quarter of 2019 and expects to receive clearance to market the device in mid-2019.
Health Medical Device Platform Technology
Is SOLY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 21 Soliton up 10% ahead of key data readout
Oct 21 Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results
Oct 15 Soliton's FDA Cleared RAP Device is Granted Two Additional Key Patents
Oct 10 Soliton announces $6.25M private placement
Oct 10 Soliton Announces $6.25 Million Private Placement
Oct 8 Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019
Oct 3 Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor's Choice
Oct 1 Soliton Completes Keloid POC Clinical Trial Treatments
Sep 24 Soliton Announces Majority of Patients Treated in Pivotal Cellulite Trial; Expects All Patients Treated by November 2019
Sep 21 The Wait Continues for Soliton Tattoo Removal
See more SOLY news...
Indicators
Indicator Value
52 Week High 29.0
52 Week Low 4.12
Average Volume 407,238
200-Day Moving Average 0.0
50-Day Moving Average 12.3142
20-Day Moving Average 12.1035
10-Day Moving Average 13.014
Average True Range 0.9275
ADX 21.64
+DI 35.6567
-DI 13.1924
Chandelier Exit (Long, 3 ATRs ) 12.0775
Chandelier Exit (Short, 3 ATRs ) 13.1025
Upper Bollinger Band 14.3145
Lower Bollinger Band 9.8925
Percent B (%b) 1.02
BandWidth 36.534887
MACD Line 0.3208
MACD Signal Line 0.063
MACD Histogram 0.2578
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.60
Resistance 3 (R3) 16.50 15.68 16.23
Resistance 2 (R2) 15.68 15.13 15.73 16.11
Resistance 1 (R1) 15.05 14.78 15.37 15.15 15.99
Pivot Point 14.23 14.23 14.39 14.28 14.23
Support 1 (S1) 13.60 13.68 13.92 13.70 12.85
Support 2 (S2) 12.78 13.33 12.83 12.73
Support 3 (S3) 12.15 12.78 12.61
Support 4 (S4) 12.25